Hemokinin-1-derived peptides have antipruritic effects in rats

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Therapeutic Targets for Neurological Diseases

• Publication date

  2015-03-16

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.14800/TTND.704
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• B-type natriuretic peptide is neither itch-specific nor functions upstream of the GRP-GRPR signaling pathway

  2014cited by this paper
• Itch-associated peptides: RNA-Seq and bioinformatic analysis of natriuretic precursor peptide B and gastrin releasing peptide in dorsal root and trigeminal ganglia, and the spinal cord

  2014cited by this paper
• Paraneoplastic pruritus presenting with Hodgkin’s lymphoma: a case report

  2014cited by this paper
• Hemokinin-1 mediates pruriceptive processing in the rat spinal cord.

  2014cited by this paper
• An amino-terminal fragment of hemokinin-1 has an inhibitory effect on pruritic processing in rats.

  2014cited by this paper
• The Cells and Circuitry for Itch Responses in Mice

  2013cited by this paper
• Efficacy and Safety of a Novel ĸ-Agonist for Managing Intractable Pruritus in Dialysis Patients

  2012cited by this paper
• Aprepitant for management of severe pruritus related to biological cancer treatments: a pilot study.

  2012cited by this paper
• Oral aprepitant in the therapy of refractory pruritus in erythrodermic cutaneous T‐cell lymphoma

  2011cited by this paper
• Targeting the Neurokinin Receptor 1 with Aprepitant: A Novel Antipruritic Strategy

  2010cited by this paper
• Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study.

  2010cited by this paper
• Aprepitant for erlotinib-induced pruritus.

  2010cited by this paper
• Dorsal horn neurons expressing NK-1 receptors mediate scratching in rats

  2010cited by this paper
• Cellular Basis of Itch Sensation

  2009cited by this paper
• Aprepitant as an antipruritic agent?

  2009cited by this paper
• Effect of the carboxyl-terminal of endokinins on SP-induced pain-related behavior.

  2009cited by this paper
• Leucine at the carboxyl-terminal of endokinins C and D contributes to elicitation of the antagonistic effect on substance P in rat pain processing.

  2007cited by this paper
• A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord

  2007cited by this paper
• Hemokinins and endokinins

  2004cited by this paper
• Characterization of the endokinins: Human tachykinins with cardiovascular activity

  2003cited by this paper
• Centrally administered hemokinin-1 (HK-1), a neurokinin NK1 receptor agonist, produces substance P-like behavioral effects in mice and gerbils.

  2003cited by this paper
• Identification, localization and receptor characterization of novel mammalian substance P-like peptides.

  2002cited by this paper
• Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis

  2000cited by this paper
• Stereospecific effects of a nonpeptidic NK1 selective antagonist, CP-96,345: antinociception in the absence of motor dysfunction.

  1991cited by this paper
• N-terminal substance P fragments inhibit the spinally induced, NK 1 receptor mediated behavioural responses in mice.

  1990cited by this paper
• Substance P(1-7) antagonizes substance P-induced aversive behaviour in mice.

  1988cited by this paper
• Biological evaluation of substance P antagonists

  1984cited by this paper

• No citing papers are available for this paper.